ArticleScientific reports2025
Impact of inter-city interactions on disease scaling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Relationship Between Urban Characteristics and Non-Communicable Diseases-Conceptual Framework of the HORUS Project.International journal of environmental research and public health · 2026Article
- Comprehensive indicators and fine granularity refine density scaling laws in rural-urban systems.Scientific reports · 2026Article
- Scaling COVID-19 rates with population size in the United States.Journal of the Royal Society, Interface · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Inter-city interactions are critical for the transmission of infectious diseases, yet their effects on the scaling of disease cases remain largely underexplored. Here, we use the commuting network as a proxy for inter-city interactions, integrating it with a general scaling framework to describe the incidence of seven infectious diseases across Brazilian cities as a function of population size and the number of commuters. Our models significantly outperform traditional urban scaling approaches, revealing that the relationship between disease cases and a combination of population and commuters varies across diseases and is influenced by both factors. Although most cities exhibit a less-than-proportional increase in disease cases with changes in population and commuters, more-than-proportional responses are also observed across all diseases. Notably, in some small and isolated cities, proportional rises in population and commuters correlate with a reduction in disease cases. These findings suggest that such towns may experience improved health outcomes and socioeconomic conditions as they grow and become more connected. However, as growth and connectivity continue, these gains diminish, eventually giving way to challenges typical of larger urban areas - such as socioeconomic inequality and overcrowding - that facilitate the spread of infectious diseases. Our study underscores the interconnected roles of population size and commuter dynamics in disease incidence while highlighting that changes in population size exert a greater influence on disease cases than variations in the number of commuters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.